Bagheri Zohreh, Moeinzadeh Leila, Razmkhah Mahboobeh
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
J Oncol. 2022 Mar 23;2022:3845104. doi: 10.1155/2022/3845104. eCollection 2022.
Cancer as a second leading cause of death arises from multifactorial pathology. The association of microbiota and their products with various pathologic conditions including cancer is receiving significant attention over the past few years. Mounting evidence showed that human microbiota is an emerging target in tumor onset, progression, prevention, and even diagnosis. Accordingly, modulating this composition might influence the response to tumor therapy and therapeutic resistance as well. Through this review, one could conceive of complex interaction between the microbiome and cancer in either positive or negative manner by which may hold potential for finding novel preventive and therapeutic strategies against cancer.
癌症作为第二大致死原因,源于多因素病理过程。在过去几年中,微生物群及其产物与包括癌症在内的各种病理状况之间的关联受到了广泛关注。越来越多的证据表明,人类微生物群是肿瘤发生、发展、预防乃至诊断的一个新靶点。因此,调节这种组成可能也会影响对肿瘤治疗的反应和治疗耐药性。通过这篇综述,人们可以以积极或消极的方式设想微生物组与癌症之间的复杂相互作用,这可能为寻找新的癌症预防和治疗策略提供潜力。